JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) - Total Liabilities

Latest as of September 2025: $23.80 Million USD

Based on the latest financial reports, JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has total liabilities worth $23.80 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore ZJYL cash flow conversion to assess how effectively this company generates cash.

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Total Liabilities Trend (2018–2025)

This chart illustrates how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of JIN MEDICAL INTERNATIONAL LTD. Ordinary to evaluate the company's liquid asset resilience ratio.

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Competitors by Total Liabilities

The table below lists competitors of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares ranked by their total liabilities.

Company Country Total Liabilities
Integrum AB Series B
ST:INTEG-B
Sweden Skr22.09 Million
K-One Technology Bhd
KLSE:0111
Malaysia RM86.47 Million
Bluglass Ltd
AU:BLG
Australia AU$9.69 Million
Alpha Group International plc
LSE:ALPH
UK GBX294.65 Million
Fancamp Exploration Ltd.
V:FNC
Canada CA$7.70 Million
Caspin Resources Ltd
AU:CPN
Australia AU$1.01 Million
Zodiac Clothing Company Limited
NSE:ZODIACLOTH
India Rs1.63 Billion

Liability Composition Analysis (2018–2025)

This chart breaks down JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see JIN MEDICAL INTERNATIONAL LTD. Ordinary market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.86 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.80 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.45 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2018–2025)

The table below shows the annual total liabilities of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2018 to 2025.

Year Total Liabilities Change
2025-09-30 $23.80 Million +37.96%
2024-09-30 $17.25 Million +93.27%
2023-09-30 $8.92 Million +56.46%
2022-09-30 $5.70 Million -27.54%
2021-09-30 $7.87 Million -21.38%
2020-09-30 $10.01 Million +3.69%
2019-09-30 $9.66 Million -0.22%
2018-09-30 $9.68 Million --

About JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares

NASDAQ:ZJYL USA Medical Instruments & Supplies
Market Cap
$363.19 Million
Market Cap Rank
#24745 Global
#5049 in USA
Share Price
$2.32
Change (1 day)
+9.95%
52-Week Range
$0.12 - $2.52
All Time High
$13.81
About

Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs … Read more